Patient Stories
David Jones suffered from viral myocarditis but avoided a heart transplant through six days of Bi-VAD BVS 5000 support. Read More >
Abiomed Appoints David Weber as Chief Operating Officer
Abiomed Completes Enrollment of Pilot Clinical Trial for Impella 2.5 Circulatory Support System
Abiomed to Showcase Circulatory Support Technologies at International Society for Heart and Lung Transplantation Meeting
Abiomed Announces Australian Regulatory Approval of Impella Circulatory Support Technologies
Abiomed's Impella 2.5 Circulatory Support System Receives Medical Design Excellence Award
Abiomed Expands Availability of Impella Circulatory Support Technologies with Regulatory Approvals in India
Abiomed Announces Data on Impella 2.5 for Improved Cardiac Function for Pre-Shock Acute Myocardial Infarction
Abiomed, Inc. Closes Sale of Common Stock in Public Offering
Abiomed's Clinical Webcast: Anticoagulation 101
Click here to listen to the rebroadcast.
